Trial Profile
Study of E7070 Combined With Capecitabine to Determine Efficacy and Recommended Dose of Combination in Patients With Metastatic Colorectal Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Aug 2014
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Indisulam (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Sponsors Eisai Co Ltd
- 13 Sep 2005 New trial record.